Furthermore, it reveals a unique genomic profile including mutations in driver genes and drug‐resistant genes, TP53 LOH, a number of CNVs, and more mutated genes than plasma, indicating the potential existence of genomic instability in LM tumors. Here, TP53 is linked to lymphangioma.